HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

rat PDCD5 protein

Also Known As:

PDCD5 protein, rat; AM-101; TF-1 cell apoptosis related gene-19, rat; TFAR19 protein, rat; programmed cell death 5 protein, rat

Networked: 5 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Intracellular Signaling Peptides and Proteins: 32
    - Apoptosis Regulatory Proteins: 2514
      - rat PDCD5 protein: 5
- Peptides: 82426
  - Intracellular Signaling Peptides and Proteins: 32
    - Apoptosis Regulatory Proteins: 2514
      - rat PDCD5 protein: 5

Experts

1.	Meyer, Thomas: 3 articles (01/2017 - 04/2014)
2.	Staecker, Hinrich: 2 articles (01/2017 - 01/2015)
3.	Morawski, Krzysztof: 2 articles (01/2015 - 04/2014)
4.	van de Heyning, Paul: 2 articles (01/2015 - 04/2014)
5.	Ahn, Joong Ho: 1 article (01/2017)
6.	Chrbolka, Pavel: 1 article (01/2017)
7.	Kramer, Timothy: 1 article (01/2017)
8.	Morelock, Michael: 1 article (01/2017)
9.	Bing, Dan: 1 article (01/2015)
10.	Campanelli, Dario: 1 article (01/2015)

Related Diseases

1.	Tinnitus 04/01/2014 - "Efficacy and safety of AM-101 in the treatment of acute inner ear tinnitus--a double-blind, randomized, placebo-controlled phase II study." 01/01/2015 - "Selecting appropriate dose regimens for AM-101 in the intratympanic treatment of acute inner ear tinnitus." 01/01/2015 - "Local round-window application of AM-101 may be a promising therapeutic intervention for the treatment of synaptopathic tinnitus." 01/01/2017 - "Safety of Repeated-Dose Intratympanic Injections with AM-101 in Acute Inner Ear Tinnitus." 01/01/2011 - "Safety of intratympanic injection of AM-101 in patients with acute inner ear tinnitus."
2.	Wounds and Injuries (Trauma) 01/01/2015 - "We have shown that AM-101 reduced the trauma-induced loss of IHC ribbons and counteracted the decline of ABR wave I amplitude generated in the cochlea/auditory nerve. " 04/01/2014 - "However, AM-101 0.81 mg/ml showed statistically significantly better improvement for tinnitus loudness, annoyance, sleep difficulties, and tinnitus impact in patients with tinnitus after noise trauma or otitis media. "
3.	Otitis Media 01/01/2017 - "Subjects and Methods In total, 343 subjects with persistent acute tinnitus after traumatic cochlear injury or otitis media were randomized to receive 3 intratympanic doses of either AM-101 0.87 mg/mL or placebo over 3 to 5 days. " 04/01/2014 - "However, AM-101 0.81 mg/ml showed statistically significantly better improvement for tinnitus loudness, annoyance, sleep difficulties, and tinnitus impact in patients with tinnitus after noise trauma or otitis media. " 04/01/2014 - "To evaluate the efficacy and safety of intratympanic AM-101 in patients with persistent acute inner ear tinnitus after acute acoustic trauma, idiopathic sudden sensorineural hearing loss (ISSNHL), or acute otitis media. "
4.	Sensorineural Hearing Loss 04/01/2014 - "To evaluate the efficacy and safety of intratympanic AM-101 in patients with persistent acute inner ear tinnitus after acute acoustic trauma, idiopathic sudden sensorineural hearing loss (ISSNHL), or acute otitis media. "
5.	Noise-Induced Hearing Loss (Acoustic Trauma) 04/01/2014 - "To evaluate the efficacy and safety of intratympanic AM-101 in patients with persistent acute inner ear tinnitus after acute acoustic trauma, idiopathic sudden sensorineural hearing loss (ISSNHL), or acute otitis media. "

Related Drugs and Biologics

1.	Glutamic Acid (Glutamate)
2.	N-Methyl-D-Aspartate Receptors (NMDA Receptors)
3.	N-Methylaspartate (NMDA)
4.	Esketamine

Related Therapies and Procedures

1.	Intratympanic Injection